Thus, its tumor suppression activity is abolished due to disruption in CDKN1A and SMAD3 pathway which is related to cell cycle regulation and aberrant activation of PI3K/AKT pathway (Bosse et al., 2013). The gene discussed is AKT1; the disease is neoplasm.